R3	Coref Anaphora:T21 Antecedent:T49
R4	Coref Anaphora:T46 Antecedent:T50
T1	Protein 0 8	TNFalpha
T2	Protein 822 830	TNFalpha
T3	Protein 850 858	TNFalpha
T4	Protein 862 870	IL-1beta
T5	Protein 908 919	p24 antigen
T6	Protein 1100 1108	TNFalpha
T7	Protein 1149 1157	IL-1beta
T8	Protein 1185 1193	TNFalpha
T9	Protein 1198 1206	IL-1beta
T10	Protein 1426 1434	TNFalpha
T11	Protein 1446 1454	IL-1beta
T12	Protein 1695 1703	TNFalpha
T49	Exp 490 514	cAMP-responsive elements
T50	Exp 1802 1813	a mechanism
T15	Exp 25 53	the protein kinase A pathway
T16	Exp 247 280	the transcription initiation site
T17	Exp 284 297	the U5 region
T18	Exp 301 331	the HIV-1 long terminal repeat
T19	Exp 339 373	These downstream sequence elements
T20	Exp 452 454	we
T21	Exp 528 532	they
T22	Exp 468 472	that
T23	Exp 473 480	the DSE
T24	Exp 709 711	we
T25	Exp 724 728	that
T26	Exp 690 707	the present study
T27	Exp 729 742	the HIV-1 DSE
T28	Exp 755 782	the transcriptional synergy
T29	Exp 795 810	the combination
T30	Exp 1015 1019	that
T31	Exp 1032 1045	the DSE sites
T32	Exp 1056 1080	the LTR-mediated synergy
T33	Exp 1118 1129	the synergy
T34	Exp 1234 1265	the cAMP/PKA activation pathway
T35	Exp 1342 1344	we
T36	Exp 1314 1321	the DSE
T37	Exp 1354 1364	the effect
T38	Exp 1368 1392	the agonist combinations
T39	Exp 1563 1567	that
T40	Exp 1568 1606	the TRE-like cAMP-responsive DSE sites
T41	Exp 1614 1619	the 5
T42	Exp 1653 1686	the transcriptional cooperativity
T43	Exp 1708 1728	the cAMP/PKA pathway
T44	Exp 1543 1553	These data
T45	Exp 1791 1793	we
T46	Exp 1817 1822	which
T47	Exp 1736 1757	the DSE and TRE sites
T48	Exp 1823 1836	the HIV-1 DSE
